Friendly takeover offer for Patheon values contract drug maker at US$1.4 billion + MORE Nov 19th

TSX getting you down? There are always sound investment alternatives.
Latest News

4.5 year - 2.50% + MORE Nov 1st

This GIC rate is offered by DUCA Financial Services and was updated on 2014-06-13. Click on the link above to get more details or apply online..... More »

China memory chipmaker CXMT's shares soar in a blockbuster share listing in Shanghai Jul 27th

HONG KONG (AP) — Shares of CXMT, China's largest memory chipmaker, soared Monday after they began trading in Shanghai in mainland China’s biggest initial public stock offering in recent years..... More »

The week's best web reads: 10 high-conviction purchases of top stock pickers + MORE May 31st

Inside the Market's weekend roundup of some of this week's best investing reads on the Internet. .... More »

Before the Bell: What every Canadian investor needs to know today - The Globe and Mail Mar 17th

Before the Bell: What every Canadian investor needs to know today  The Globe and MailCoronavirus: TSX, Wall Street pause trading for a 3rd time as stocks collapse  Global NewsWhat every Canadian investor needs to know today  The Globe and MailNorth American stock market.... More »

Delta variant is forcing U.S. officials to rethink COVID-19 measures, even for the vaccinated - CTV News Jun 29th

Delta variant is forcing U.S. officials to rethink COVID-19 measures, even for the vaccinated  CTV NewsPfizer, Moderna Vaccines Likely to Produce Long-Lasting Immunity, Study Suggests  Yahoo News CanadaOntario reports 210 new COVID-19 cases as more adults now eligible for an acce.... More »
TORONTO – Patheon Inc. (TSX:PTI) has received a friendly going-private proposal that values the TSX-listed company at about US$1.4 billion, more than 50 per cent above its recent market price.
The offer of US$9.32 per share cash for minority shareholders is coming from a group backed by Patheon’s largest shareholder, U.S. private equity firm JLL Partners.
JLL and European life sciences company Royal DSM plan to combine Patheon into a new global contract drug manufacturer with 23 locations around the world and 8,300 employees.
The new company will be owned 51 per cent by JLL and 49 per cent by Royal DSM.
JLL Partners currently owns about 55.7 per cent of Patheon’s equity.
As a result, the takeover offer would cost about US$582 million cash to buy out shareholders other than JLL and its affiliates.
Patheon shares closed Monday at C$5.94 at the Toronto Stock Exchange, giving it a market value of C$837 million at the time.
The post Friendly takeover offer for Patheon values contract drug maker at US$1…

Continue Reading On canadianbusiness.com »

With traditional assets looking scary, investors are piling into fine art – and breaking sales records

Continue Reading On theglobeandmail.com »

Bay TodayBusy day for MPs studying federal budget, Canada-EU trade agreementMontreal GazetteOTTAWA – Members of Parliament will be busy today at committees dealing with the economy and trade. Citizenship and Immigration Minister Chris Alexander appears before a Commons committee hearing witnesses on Bill C-4, the Budget Implementation …Ottawa agenda for Monday: Parliament returns, economy, investment and healthWinnipeg Free Pressall 18 news articles »

Continue Reading On Montrealgazette.com »

5.5 year – 3.00%

– ratesupermarket.ca

This GIC rate is offered by Outlook Financial and was updated on 2013-10-30. Click on the link above to get more details or apply online.

Continue Reading On ratesupermarket.ca »

The virtual currency known as Bitcoin took a step away from the margins of the financial system Monday, as the U.S. Senate homeland security and governmental affairs committee set aside a good chunk of the afternoon for testimony on whether the …

Continue Reading On theglobeandmail.com »

Share

PinIt
Compare insurance quotes through Kanetix.ca - save time and money!